CDC: MRSA USA600 Not Worse Than Other MRSA Strains
Paul G. Auwaerter, clinical director of the Division of Infectious Diseases at Johns Hopkins University School of Medicine in Baltimore, and who was on the panel when Moore presented her report, agrees.
"It's too early to tell" if USA600 represents a new threat to patient safety, he says, because the number—16—is too small. "Who knows?" he says. "This may be a signal.
"Detroit tends to be a place where they have an intensive drug using population—and although it wasn't clear whether these patients had been intravenous drug users," he says. "we remembered that in the 1970s, some of the first signs of bad staph aureus came from Detroit.
"This is interesting to point out and it definitely bears more investigation," he says.
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- Reform Puts Vise Grips on Physicians
- Look Beyond Nurse-Patient Ratios
- Medicare Opt-Out a Viable Physician Strategy
- Hospital Groups Back NQF Report on Patient Sociodemographics
- NPP Demand Rising Under Value-Based Care Models
- Boston Marathon Bombing Yields Lessons for Hospitals
- Providers Lag as Consumers Set Agenda
- The Flourishing Medical Tourism Business in America
- Physicians as Economic Powerhouses and Tech Laggards
- How Physicians Can Help Ease Mental Health Provider Shortages